-
1دورية أكاديمية
المؤلفون: ElSayed S; Department of Biomedical and Pharmaceutical Sciences, Chapman University, Irvine, CA, United States., Jay GD; Department of Emergency Medicine, Rhode Island Hospital, Providence, RI, United States., Cabezas R; Department of Emergency Medicine, Rhode Island Hospital, Providence, RI, United States., Qadri M; Department of Pharmacology, School of Pharmacy, Jazan University, Jazan, Saudi Arabia., Schmidt TA; Biomedical Engineering Department, University of Connecticut Health Center, Farmington, CT, United States., Elsaid KA; Department of Biomedical and Pharmaceutical Sciences, Chapman University, Irvine, CA, United States.
المصدر: Frontiers in immunology [Front Immunol] 2021 Dec 21; Vol. 12, pp. 771677. Date of Electronic Publication: 2021 Dec 21 (Print Publication: 2021).
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
مواضيع طبية MeSH: Anti-Inflammatory Agents/*therapeutic use , Gout/*drug therapy , Interleukin-1beta/*immunology , Proteoglycans/*therapeutic use, Acetylcysteine/pharmacology ; Adult ; Aged ; Aged, 80 and over ; Animals ; Anti-Inflammatory Agents/pharmacology ; Female ; Free Radical Scavengers/pharmacology ; Gout/immunology ; Humans ; Interleukin 1 Receptor Antagonist Protein/antagonists & inhibitors ; Leukocytes, Mononuclear/drug effects ; Leukocytes, Mononuclear/immunology ; Male ; Mice ; Mice, Knockout ; Middle Aged ; Neutrophils/drug effects ; Neutrophils/immunology ; Phagocytosis/drug effects ; Protein Phosphatase 2/immunology ; Proteoglycans/genetics ; Proteoglycans/pharmacology ; Reactive Oxygen Species/immunology ; Recombinant Proteins/pharmacology ; Recombinant Proteins/therapeutic use ; THP-1 Cells ; Uric Acid